Company / Revenue per Share
Medpace Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$82.60
FY2025
5-year range
$25.72 / $82.60
FY2021-FY2025
Trend
+20.4%
vs FY2024
Sector context
#26 of 153
Health Care
What the data says
Medpace's revenue per share of $82.60 is higher than 83% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $25.72 in FY2022 to $82.60 in FY2025.
Based on SEC 10-K filings.
82.60 in FY2025 with a 5-year CAGR of +26.3%. Top quartile in the Health Care sector.
Improved from $60.65 to $82.60 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +47.5%
- 5-Year CAGR
- +26.3%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 153This company $82.60 Sector average $123.62
▼
-33.2% below sector average
Key checks
Key Insights
- Medpace's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 20.4% year-over-year.
- Ranks #26 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $82.60 | +20.4% |
| FY2024 | $68.58 | +13.1% |
| FY2023 | $60.65 | +135.9% |
| FY2022 | $25.72 | -20.0% |
| FY2021 | $32.16 | +25.3% |
| FY2020 | $25.67 | +6.4% |
| FY2019 | $24.14 | +103.1% |
| FY2018 | $11.89 | +10.8% |
| FY2017 | $10.73 | -17.0% |
| FY2016 | $12.92 | +12.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026